Key result
Propofol-dexmedetomidine continuous infusion during open-heart surgery significantly reduced 24-hour postoperative cardiac troponin I levels compared to propofol alone.
Why the study?
Myocardial protection in cardiac surgery requires multimodal perioperative approaches to reduce myocardial oxygen demand and prevent postoperative cardiac complications, prompting evaluation of propofol-dexmedetomidine infusion.
Does the addition of dexmedetomidine to propofol continuous infusion reduce myocardial injury biomarkers in adult patients undergoing elective CABG surgery?
RCT (n=60)
Double-blind
Sealed envelope technique
No
Does the addition of dexmedetomidine to propofol continuous infusion reduce myocardial injury biomarkers in adult patients undergoing elective CABG surgery?
The addition of dexmedetomidine to propofol during open-heart surgery significantly reduces myocardial injury biomarkers, fentanyl requirements, and ICU length of stay compared to propofol alone.
Answers are grounded in this paper and cite their sources.
Supports myocardial protection with adjunct dexmedetomidine in open-heart surgery; extends RCT evidence on perioperative cardioprotection.
Background: Myocardial protection in cardiac surgeries is a must and requires multimodal approaches in perioperative period to decrease and prevent the increase of myocardial oxygen demand and consumption that lead to postoperative cardiac complications including myocardial ischemia, dysfunction, and heart failure. Study Design: Prospective, controlled, randomized, double-blinded study. Aims: This study aims to study the effect of propofol-dexmedetomidine continuous infusion cardioprotection during open-heart surgery in adult patients. Materials and Methods: h then every 30 min after weaning from CPB till the end of the surgery. Serum biomarkers; cardiac troponin (cTnI) and creatine kinase-myocardial bound (CK-MB) samples were measured basally (T1), 15 min after unclamping of the aorta (T2), immediate postoperative (T3), and 24 h postoperative (T4). Intraoperative data were also recorded including the number of coronary grafts, aortic cross-clamping duration, duration of cardiopulmonary bypass (CPB), duration of surgery, and rhythm of reperfusion. Fentanyl requirement, extubation time, and length of intensive care unit (ICU) stay were also recorded for every case. Results: There was no statistically significant differences as regard to demographic data between the studied two groups. HR and blood pressure recorded was lower in the PD group than the control group, and this difference was noted to be statistically significant. Furthermore, the PD group showed lower levels of myocardial enzymes (cTnI and CK-MB), decreased total fentanyl requirement, earlier postoperative extubation, and shorter ICU stay than the P(control) group. Conclusion: The use of propofol-dexmedetomidine in CPB surgeries offers more cardioprotective effects than the use of propofol alone.
No takes yet. Share an insight, caveat, or question.
Elgebaly et al. (2020) conducted an RCT in Coronary heart disease requiring open-heart surgery (n=60). Propofol-dexmedetomidine vs. Propofol 2 mg/kg/h and placebo (0.9% sodium chloride) was evaluated on Cardiac troponin I (cTnI) level at 24 hours postoperative (p=<0.001). Propofol-dexmedetomidine continuous infusion during open-heart surgery significantly reduced 24-hour postoperative cardiac troponin I levels compared to propofol alone.
Synapse has enriched 10 related papers. Consider them for comparative context: